Daily MDOI Identifier Registry

Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review

A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review

An Acquired Taste: Latent Class Analysis to Compare Adolescent and Adult Preferences for EQ-5D-Y-3L Health States

Development and Testing of the Psychometric Properties of 20 Bolt-On Items for the EQ-5D-5L Across 31 Rare Diseases

Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People With Diabetes

Managing Uncomplicated Singleton Breech Pregnancy Using the OptiBreech Collaborative Care Pathway: Early Economic Model and Value of Information Analysis

The Price Effects of Biosimilars in the United States

Are Updated COVID-19 Vaccines Still Relevant for All Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia

Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate Cancer

Newer Glucagon-Like Peptide-1 Receptor Agonists Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: A Population-Level Time Series Analysis

Public Health Supports Whole Health

Whole Health: A Global Perspective

Taking Health Economics and Outcomes Research Forward: Expanding the Definition of Value to Include Whole Health

What Does ‘Whole Health’ Really Mean for Health Economics and Outcomes Research?

Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products

Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases

Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions

Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions

How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report

How Do Bundled Payment Initiatives Account for Differences in Patient Risk Profiles? A Systematic Review

The Application of Time-Driven Activity-Based Costing in Oncology: A Systematic Review

A United Kingdom Value Set for the Weight-Specific Adolescent Instrument for Economic Evaluation

How Do Individuals Value Worse-Than-Dead EQ-5D-5L Health States in Composite Time Trade-Off Tasks? A Qualitative Study

A Value Set for EQ-5D-5L in the United Arab Emirates

A Comparison of the Performance of 6 Surrogacy Models, Including Weighted Linear Regression, Meta-Regression, and Bivariate Meta-Analysis

Role of Health Equity in Health Technology Assessment Processes: A Landscape Analysis of 13 Health Systems in Asia

Using Outcome Information During Consultation Yields Better Shared Decision Making, Better Patient Experiences, and More Positive Expectations: A Comparative Effectiveness Study

Age and Gender Differences in the Relationship Between Chronic Pain and Dementia Among Older Australians

Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study

A New Approach for Assessing the Value of Informal Care in Alzheimer’s Disease

The Excess Direct Social Costs of Dementia-Related Neuropsychiatric Symptoms: A Regionwide Cohort Study Beyond Silos

Cost-Effectiveness of a Digitally Supported Care Management Program for Caregivers of People With Dementia

Indirect Costs of Alzheimer’s Disease: Unpaid Caregiver Burden and Patient Productivity Loss

New IPECAD Open-Source Model Framework for the Health Technology Assessment of Early Alzheimer’s Disease Treatment: Development and Use Cases

IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease

The Health Economics of Alzheimer’s Disease and Related Dementias

Economic Considerations in Designs and Modifications of Multiarm, Multistage Adaptive and Adaptive Platform Randomized Controlled Trials: A Systematic Literature Review

A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale Scores

Developing an Australian Value Set for the Recovering Quality of Life-Utility Index Instrument Using Discrete Choice Experiment With Duration

The Psychometric Properties of the EQ-HWB and EQ-HWB-S in Patients With Breast Cancer: A Comparative Analysis With EQ-5D-5L, FACT-8D, and SWEMWBS

The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy

Does Regulatory and Reimbursement Parallel Processing Provide Swifter Funded Access to Medicines for Patients? Evaluation of Cancer Medicines Using the Australian Parallel Process

Social Return on Investment Analysis: A Mixed Methods Approach to Assessing the Value of Adult Hospice Services

Evaluating the Health and Economic Impacts of Return-to-Work Interventions: A Modeling Study

Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis

Economic Evaluation of 9 Intersectoral Strategies to Improve Youth Mental Health and Alleviate Financial Burden in Colombia Using System Dynamics Modeling

The Impact of Chronic Conditions on Productivity-Adjusted Life-Years in Both the Workplace and Household Settings in the General Adult Population in Finland

The Estimation of Health State Utility Values for Psychological Distress in Australia: Implications for Future Economic Evaluations

The Estimation of Health State Utility Values for Psychological Distress in Australia: Implications for Future Economic Evaluations

Cost-Utility Analysis of Antipsychotic Reduction and Discontinuation in Patients With Long-Term Schizophrenia and Psychosis in English Mental Health Trusts: The RADAR Study